| Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab SV Bratman, SYC Yang, MAJ Iafolla, Z Liu, AR Hansen, PL Bedard, ... Nature Cancer 1 (9), 873-881, 2020 | 331 | 2020 |
| EVOLVE: a multicenter open-label single-arm clinical and translational phase II trial of cediranib plus olaparib for ovarian cancer after PARP inhibition progression S Lheureux, A Oaknin, S Garg, JP Bruce, A Madariaga, NC Dhani, ... Clinical Cancer Research 26 (16), 4206-4215, 2020 | 96 | 2020 |
| Implementation and outcomes of virtual care across a tertiary cancer center during COVID-19 A Berlin, M Lovas, T Truong, S Melwani, J Liu, ZA Liu, A Badzynski, ... JAMA oncology 7 (4), 597-602, 2021 | 88 | 2021 |
| Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency A Das, S Sudhaman, D Morgenstern, A Coblentz, J Chung, SC Stone, ... Nature medicine 28 (1), 125-135, 2022 | 87 | 2022 |
| Pathological upstaging of clinical T1 to pathological T3a renal cell carcinoma: a multi-institutional analysis of short-term outcomes JG Nayak, P Patel, O Saarela, Z Liu, A Kapoor, A Finelli, S Tanguay, ... Urology 94, 154-160, 2016 | 75 | 2016 |
| Safety, reliability and accuracy of small renal tumour biopsies: results from a multi‐institution registry PO Richard, MAS Jewett, S Tanguay, O Saarela, ZA Liu, F Pouliot, ... BJU international 119 (4), 543-549, 2017 | 69 | 2017 |
| Curative-intent metastasis-directed therapies for molecularly-defined oligorecurrent prostate cancer: a prospective phase II trial testing the oligometastasis hypothesis RM Glicksman, U Metser, D Vines, J Valliant, Z Liu, PW Chung, ... European urology 80 (3), 374-382, 2021 | 64 | 2021 |
| Quantitative 68Ga-DOTATATE PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with 177Lu-DOTATATE C Ortega, RKS Wong, J Schaefferkoetter, P Veit-Haibach, S Myrehaug, ... Journal of Nuclear Medicine 62 (10), 1406-1414, 2021 | 57 | 2021 |
| The natural history of renal function after surgical management of renal cell carcinoma: results from the Canadian Kidney Cancer Information System R Mason, A Kapoor, Z Liu, O Saarela, S Tanguay, M Jewett, A Finelli, ... Urologic Oncology: Seminars and Original Investigations 34 (11), 486. e1-486. e7, 2016 | 53 | 2016 |
| Factors influencing disease progression of prostate cancer under active surveillance: a McGill University Health Center cohort GA Barayan, F Brimo, LR Bégin, JA Hanley, Z Liu, W Kassouf, ... BJU international 114 (6b), E99-E104, 2014 | 53 | 2014 |
| Disease progression and kidney function after partial vs. radical nephrectomy for T1 renal cancer CM Forbes, RA Rendon, A Finelli, A Kapoor, RB Moore, RH Breau, ... Urologic Oncology: Seminars and Original Investigations 34 (11), 486. e17 …, 2016 | 46 | 2016 |
| Recovering the raw data behind a non-parametric survival curve Z Liu, B Rich, JA Hanley Systematic reviews 3, 1-10, 2014 | 46 | 2014 |
| Positive surgical margins during partial nephrectomy for renal cell carcinoma: Results from Canadian Kidney Cancer information system (CKCis) collaborative RK Bansal, S Tanguay, A Finelli, R Rendon, RB Moore, RH Breau, ... Canadian Urological Association Journal 11 (6), 182, 2017 | 35 | 2017 |
| Contemporary dose-escalation methods for early phase studies in the immunotherapeutics era DV Araujo, M Oliva, K Li, R Fazelzad, ZA Liu, LL Siu European Journal of Cancer 158, 85-98, 2021 | 30 | 2021 |
| Intellectual changes after radiation for children with brain tumors: which brain structures are most important? DS Tsang, L Kim, ZA Liu, L Janzen, M Khandwala, E Bouffet, N Laperriere, ... Neuro-oncology 23 (3), 487-497, 2021 | 20 | 2021 |
| Rapid adaptation of breast radiation therapy use during the coronavirus disease 2019 pandemic at a large academic cancer center in Canada CA Koch, G Lee, ZA Liu, FF Liu, A Fyles, K Han, A Barry, J Croke, D Rodin, ... Advances in Radiation Oncology 5 (4), 749-756, 2020 | 20 | 2020 |
| Intraoperative fluorescence imaging with aminolevulinic acid detects grossly occult breast cancer: a phase II randomized controlled trial K Ottolino-Perry, A Shahid, S DeLuca, V Son, M Sukhram, F Meng, ZA Liu, ... Breast Cancer Research 23, 1-20, 2021 | 19 | 2021 |
| Detection of clinically significant prostate cancer with 18F-DCFPyL PET/multiparametric MR U Metser, C Ortega, N Perlis, E Lechtman, A Berlin, R Anconina, Y Eshet, ... European Journal of Nuclear Medicine and Molecular Imaging 48, 3702-3711, 2021 | 19 | 2021 |
| Measuring the mortality impact of breast cancer screening JA Hanley, M McGregor, Z Liu, EC Strumpf, N Dendukuri Canadian Journal of Public Health 104, e437-e442, 2013 | 19 | 2013 |
| Genomic microsatellite signatures identify germline mismatch repair deficiency and risk of cancer onset J Chung, L Negm, V Bianchi, L Stengs, A Das, ZA Liu, S Sudhaman, ... Journal of Clinical Oncology 41 (4), 766-777, 2023 | 18 | 2023 |
